1.1 Genomic and chromosomal instability in CML An unstable genome is a common hallmark of nearly all solid tumors and most of leukemias in contrast to normal, healthy cells which are able to maintein genome integrity (Negrini et al., 2010). Genomic instability could result from changes in chromosome structure an
The hallmark of chronic myeloid leukemia (CML) and a subset of acute lymphoblastic leukemia (ALL) is...
Chronic myeloid leukemia (CML) is a two-stage disease caused by the p210 BCR-ABL protein. BCR-ABL is...
The emergence of additional chromosomal abnormalities (ACAs) in Philadelphia chromosome/BCR-ABL1 pos...
The most recent two decades have seen tremendous progress in the understanding and treatment of chro...
The Bcr-abl translocation arises from a reciprocal translocation between chromosomes 9 and 22 and re...
Genomic instability is a common feature of cancer cells, which can result from aberrant DNA damage r...
Chronic myeloid leukemia (CML) is a malignant clonal disorder of the hematopoietic system caused by ...
Chronic myelogenous leukemia (CML) is the first cancer known to be associated with reciprocal transl...
Chronic myeloid leukemia (CML) is a two-stage disease caused by the p210 BCR-ABL protein. BCR-ABL is...
Chronic myelogenous leukemia (CML) is a disease arising from a reciprocal translocation between chro...
Chronic myeloid leukemia (CML) is a malignant clonal disorder of the hematopoietic system caused by ...
The expression of the chimeric BCR/ABL1 fusion gene resulting from t(9;22)(q34;q11) in chronic myelo...
Chronic myeloid leukemia (CML) is a malignant clonal disorder of the hematopoietic system caused by ...
Chronic myeloid leukemia (CML) has been the first human malignancy to be associated, more than 50 ye...
Chronic myeloid leukaemia (CML) is caused by the product of the BCR-ABL oncogene, located on the Phi...
The hallmark of chronic myeloid leukemia (CML) and a subset of acute lymphoblastic leukemia (ALL) is...
Chronic myeloid leukemia (CML) is a two-stage disease caused by the p210 BCR-ABL protein. BCR-ABL is...
The emergence of additional chromosomal abnormalities (ACAs) in Philadelphia chromosome/BCR-ABL1 pos...
The most recent two decades have seen tremendous progress in the understanding and treatment of chro...
The Bcr-abl translocation arises from a reciprocal translocation between chromosomes 9 and 22 and re...
Genomic instability is a common feature of cancer cells, which can result from aberrant DNA damage r...
Chronic myeloid leukemia (CML) is a malignant clonal disorder of the hematopoietic system caused by ...
Chronic myelogenous leukemia (CML) is the first cancer known to be associated with reciprocal transl...
Chronic myeloid leukemia (CML) is a two-stage disease caused by the p210 BCR-ABL protein. BCR-ABL is...
Chronic myelogenous leukemia (CML) is a disease arising from a reciprocal translocation between chro...
Chronic myeloid leukemia (CML) is a malignant clonal disorder of the hematopoietic system caused by ...
The expression of the chimeric BCR/ABL1 fusion gene resulting from t(9;22)(q34;q11) in chronic myelo...
Chronic myeloid leukemia (CML) is a malignant clonal disorder of the hematopoietic system caused by ...
Chronic myeloid leukemia (CML) has been the first human malignancy to be associated, more than 50 ye...
Chronic myeloid leukaemia (CML) is caused by the product of the BCR-ABL oncogene, located on the Phi...
The hallmark of chronic myeloid leukemia (CML) and a subset of acute lymphoblastic leukemia (ALL) is...
Chronic myeloid leukemia (CML) is a two-stage disease caused by the p210 BCR-ABL protein. BCR-ABL is...
The emergence of additional chromosomal abnormalities (ACAs) in Philadelphia chromosome/BCR-ABL1 pos...